Clinical Trials Logo

Clinical Trial Summary

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm


Clinical Trial Description

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allocating patients into a two-week's and a four week's randomization arm.

The adult patients are hospitalized for septic arthritis. A computer program randomizes 1:1 between a two week's and a four week's arm of targeted antibiotic treatment of which at least the first week is intravenously. The randomization may occur until Day 5 of admission. Up to three surgical interventions are allowed. The investigators allow the inclusion of all bacterial arthritis and all joints. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03615781
Study type Interventional
Source University Hospital, Geneva
Contact
Status Completed
Phase N/A
Start date June 1, 2015
Completion date May 18, 2018

See also
  Status Clinical Trial Phase
Completed NCT04460144 - Rapid Diagnostic Test for Septic Arthritis
Recruiting NCT05531227 - Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint